💉FDA Meeting on 2025-2026 COVID-19 Vaccine Formula
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-2025-2026 Formula for COVID-19 Vaccines for Use in the United States
Summary
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The committee will meet in an open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States. FDA is establishing a docket for public comment on this document.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The notice discusses a public advisory committee meeting regarding the formulation of COVID-19 vaccines, which could influence vaccine supply chains, pricing, and regulatory compliance for businesses involved in healthcare and pharmaceuticals. Business owners in these sectors should stay informed on the developments and potential changes to regulations or demand dynamics.